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AbstrACt
Objectives To examine the level of awareness of the link 
between human papillomavirus (HPV) and oropharyngeal 
cancer (OPC) and epidemiological trends in HPV-related 
OPC among general practitioners (GPs) in the UK.
Design Cross-sectional survey.
Participants 384 GPs from England, Scotland, Wales and 
Northern Ireland.
setting The survey was administered at GP training 
courses and via email to lists of training course attendees.
Primary and secondary outcome measures Proportion 
of respondents aware of the link between HPV and OPC; 
respondents’ self-rated knowledge of OPC; proportion of 
participants aware of the epidemiological trends in HPV-
associated OPC.
results 384 questionnaires were completed with an 
overall response rate of 72.9%. 74.0% of participants 
recognised HPV as a risk factor for OPC, which was lower 
than knowledge about the role of smoking, chewing 
tobacco and alcohol consumption (all >90% recognition). 
Overall, 19.4% rated their knowledge of OPC as very good 
or good, 62.7% as average and 17.7% as poor or very 
poor. The majority (71.9%) were aware that rates of HPV-
associated OPC have increased over the last two decades. 
Fewer than half (41.5%) of the participants correctly 
identified being male as a risk factor of HPV-associated 
OPC, while 58.8% were aware that patients with HPV-
associated OPC tend to be younger than those with non-
HPV-associated disease.
Conclusions The association of HPV infection with OPC 
is a relatively recent discovery. Although the level of 
awareness of HPV and OPC among GPs was high, the 
characteristics of HPV-associated OPC were less well 
recognised, indicating the need for further education.
IntrODuCtIOn 
Head and neck cancer (HNC) is a significant 
cause of morbidity and mortality with over 
11 000 new cases diagnosed in the UK each 
year.1 The most common anatomical sites are 
the oral cavity, pharynx and larynx, with over 
90% of tumours diagnosed being squamous 
cell carcinomas.2 Survival rates of HNC are 
related to histological type, primary tumour 
site, disease stage at time of diagnosis and 
aetiology. Knowledge of the symptoms, risk 
factors and epidemiology both in the general 
population and among primary care profes-
sionals is key to primary prevention and 
earlier diagnosis.3 
Research in the past decade has revealed 
the increasing importance of human papillo-
mavirus (HPV) infection as a major risk factor 
for the development of HNC, in particular 
oropharyngeal cancer (OPC).4 5 While rates 
of tobacco-related disease have decreased 
over the past two decades, there has been 
a marked increase in HPV-positive OPC in 
many high-income countries. It is estimated 
that between 55% and 95% of OPC in Europe 
is HPV-positive in younger patients.5 6 Twenty 
years ago, this figure stood at just 20%. In 
this period, the incidence of HPV-associated 
OPC in the USA has increased by 225%7 
and similar trends are observed in the UK. 
strengths and limitations of this study
 ► This study is the first to report on awareness of 
human  papillomavirus (HPV)-associated oropha-
ryngeal cancer (OPC) in a sample of UK general 
practitioners (GPs).
 ► This study included GPs from a variety of geographi-
cal regions with varying levels of experience.
 ► This study suggests that further education on the 
epidemiological trends and patient demographics of 
HPV-associated OPC may be needed to ensure early 
detection of disease.
 ► The main limitation is the unknown representative-
ness of the sample. Although the response rate was 
good, we used a convenience sample of GPs and 
trainees attending training updates, who may have 
higher or lower levels of knowledge than the wider 
population of GPs in the UK.
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In Scotland, the rates of OPC have increased more than 
those of any other cancer.8
Diagnosing HPV-positive OPC presents particular 
challenges for general practitioners (GPs) who may lack 
detailed knowledge of the disease. HPV-positive OPC 
represents a distinct molecular, epidemiological and clin-
ical entity.9 10 Compared with non-HPV associated HNC, 
HPV-positive OPC occurs at a younger age and more 
often in men compared with non-HPV-associated OPC.11 
In addition, patients presenting with HPV-positive OPC 
typically lack traditional risk factors such as smoking and 
alcohol use. Risk factors for HPV-positive OPC include 
age at first intercourse, number of sexual partners and 
number of oral sex partners.4 Early diagnosis is important; 
HPV-positive OPC is much more responsive to chemo-
therapy and radiotherapy (82% vs 55%) and has better 
overall survival rates at 2 years than non-HPV-associated 
OPC (95% vs 62%).12 The increasing rates of HNCs and 
the fact that their outcome depends on early diagnosis 
has been recognised in the GP Curriculum of the Royal 
College of General Practitioners.13
Awareness of the changing epidemiological and risk 
factor profile of OPC among primary care professionals 
is likely to lead to earlier diagnosis, resulting in improved 
outcomes, but the HPV-related learning resources recom-
mended by the RCGP Curriculum to GPs and GP Trainees 
(such as RCGP Learning, e-LfH and BMJ Learning) focus 
on cervical cancer and cervical screening. Our review of 
the literature did not identify any learning modules avail-
able to UK GPs which focus on HPV-associated OPC. In 
addition, there has been no research to establish current 
levels of knowledge about HPV-associated OPC among 
GPs in the UK, which is an essential first step in identi-
fying additional training needs in this area.
This study represents a first step towards understanding 
awareness of HPV-associated OPC among GPs in the UK, 
and to identify areas where further educational resources 
might lead to more targeted knowledge and improved 
patient outcomes.
MethODs
We carried out a cross-sectional questionnaire survey with 
GPs in the UK (online supplementary file 1; STROBE 
checklist).
Measures
We developed a short questionnaire (online supplemen-
tary file 2) assessing demographic characteristics of the 
participants, self-rated knowledge of OPC, awareness of 
OPC risk factors, awareness of time trends in smoking-re-
lated and HPV-related OPC, previous awareness of the 
link between HPV and OPC and perceptions about the 
characteristics of patients with HPV-associated as opposed 
to non-HPV OPC. Demographic characteristics included 
gender, number of years since graduation and current 
position. Self-rated level of knowledge and assessment 
of awareness of OPC was assessed using a Likert scale. 
Knowledge of the symptoms and risk factors for OCP were 
assessed using items adapted from the Cancer Awareness 
Measure.14 15 Thirteen risk factors (10 true and 3 false) 
were selected from the epidemiological literature.16 17 An 
open question was used to assess knowledge of the symp-
toms of OPC, using wording from the Cancer Awareness 
Measure. The items developed for the questionnaire were 
discussed in a multidisciplinary team including GPs and a 
behavioural scientist.
Participants and procedure
As the aims of the study were descriptive, we did not carry 
out a formal sample size calculation but aimed to recruit 
around 400 participants from a range of geographical 
locations, with varying amounts of clinical experience, in 
line with similar studies of this type.18 Eligibility criteria 
were defined as being on the General Medical Council’s 
(GMC) GP register and a local performers list or being 
currently enrolled in a recognised UK GP training post. 
The questionnaire was administered to a convenience 
sample of GPs attending courses and training meetings 
in paper format and via email lists in online format. 
Survey Monkey online platform was used to administer 
the survey via email lists. Paper questionnaires were 
added as separate collectors to the Survey Monkey data-
base to consolidate responses. The sample included three 
training events for GPs in London and the North West of 
England, and five web links sent to working groups, local 
faculties and event administrators. Each collector was 
sent and tracked separately (online supplementary table 
1; supplementary file 3). Data collection continued over a 
period of 9 months between May 2015 and February 2016.
Analysis
Statistical analysis was conducted using standard measures 
of central tendency and spread. One-way analysis of vari-
ance test was used for assessing association between years 
after graduation and awareness of HPV and OPC link. 
IBM SPSS V.20.0 software was used for statistical analysis. 
Descriptive data on the main characteristics of the sample 
have been analysed using Microsoft Excel V.2013.
Patient and public involvement
No patient and public involvement was sought during the 
preparation of the questionnaire, as our target group was 
exclusively medical professionals. However, GPs and a 
behavioural scientist were involved in the development of 
the survey who are included in the list of authors.
results
sample characteristics
A total of 96 surveys were distributed in printed form 
and 411 requests were sent by email distribution via 
online lists. Overall, 385 questionnaires were completed 
giving an overall response rate of 72.9%. Eight of the 385 
responses were disqualified. A total of 340 participants 
completed all the questions and 35 has skipped one or 
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more questions. Each question was analysed individually. 
The response rate for paper questionnaires was higher 
(85.4%) compared with online distribution (70.1%) 
(online supplementary table 1; supplementary file 3). 
The demographic characteristics of the sample are shown 
in table 1. Overall, 59.1% participants were women. The 
largest proportion of participants were from England 
(44.2%), but all parts of the UK were included (Scot-
land 27.6%, Ireland 19.6% and Wales 8.6%). About half 
(50.3%) of participants had been in practice for over 10 
years (18.4% 10–20 years and 31.9% >20 years). Just over 
a third (35.2%) of participants were in training, 33.5% 
were salaried GPs and 24.5% were GP partners, while 
6.1% reported being in a locum post. When asked about 
their self-rated knowledge of OPC, 19.4% rated their 
knowledge of OPC as very good or good, 62.9% rated 
their knowledge as average and 17.7% reported poor or 
very poor knowledge of OPCs.
Awareness of risk factors for OPC
73.9% of the participants reported being aware of the link 
between HPV and OPC while 16.9% reported not having 
heard of the association and 9.1% reported being unsure. 
Participants were asked about 13 exposures and whether 
they were risk factors of OPC or not (figure 1). Just over 
three-quarters (77.6% 271 of 349) of the participants who 
responded to the risk factor question correctly identified 
HPV as a risk factor for OPC. Awareness of other well-es-
tablished risk factors was much higher: smoking (99.4%), 
chewing tobacco (96.6%), current alcohol consumption 
(94.3%) and past alcohol consumption (86.5%). Chewing 
catchu and areca nuts, marijuana use and aflatoxin expo-
sure were less frequently recognised (32.9%, 50.4% and 
26.4%, respectively).
Knowledge of the epidemiology of hPV-associated OCP
Most participants (71.9%) correctly stated that the rates 
of HPV-associated OPC have increased in high incomes 
countries over the last two decades (table 2). However, 
fewer than half (41.5%) correctly identified HPV-asso-
ciated OPC as being more common in men. A 58.8% 
correctly reported the association with younger age. 
There were no statistically significant differences between 
years since graduation or post type and awareness of HPV 
and OPC.
DIsCussIOn
This study is the first to assess the awareness of HPV-as-
sociated OPC in a sample of UK GPs. Our results show 
that more than three-quarters of UK participants who 
responded to the risk factor question correctly iden-
tified HPV as a risk factor for OPC. However, there is 
limited awareness of the differences in the demographic 
profiles of patients presenting with HPV-associated and 
non-HPV-associated OPC as well as a lack of awareness of 
other risk factors of OPC.
Cancer of the oropharynx is now thought to be asso-
ciated with HPV in 70%–95% of younger patients5 and 
disease outcome is related to the stage of disease at diag-
nosis.3 It is therefore important that GPs, who are likely 
to be the first point of contact for patients, are able to 
recognise the characteristics of patients at risk of HPV-as-
sociated OPC in order to refer them on to secondary and 
tertiary care as early as possible. These patients may be 
younger and may not have any history of smoking and 
drinking, in contrast to the risk factor profiles of patients 
with traditional HNC.
Our study demonstrates that further education on the 
epidemiological trends and patient demographics of 
HPV-associated OPC is needed to ensure early detection 
of disease. We provide a learning module which can be 
accessed online (online supplementary file 4; HPV-asso-
ciated Oropharyngeal Cancer Module). GP awareness of 
the role of HPV in OPC may also lead to more support for 
the continued high uptake of national HPV vaccination 
Table 1 Demographic characteristics of the sample and 
self-rated knowledge of OPC (n=376)
N %
Gender
  Male 154 40.9
  Female 222 59.1
Stage of training/position
  F2 6 1.6
  GPST1 44 11.7
  GPST2 36 9.6
  GPST3 49 13.1
  GP (salaried or 
partnered)
218 57.9
  Locum 23 6.1
Years since graduation
  <2 17 4.4
  2–5 81 21.9
  5–10 93 24.2
  10–20 69 17.9
  20+ 124 32.3
Location of current practice (n=373)
  England 165 44.2
  Scotland 103 27.6
  Wales 32 8.6
  Northern Ireland 73 19.6
Self-rated knowledge of OPC (n=350)
  Very poor 5 1.4
  Poor 57 16.3
  Average 220 62.9
  Good 65 18.6
  Very good 3 0.9
GP, general practitioner; OPC, oropharyngeal cancer.
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programmes, thereby maximising opportunity to ensure 
both individual and herd protection.
strengths and limitations
Our study is the first to assess the awareness of HPV-associ-
ated OPC in a sample of UK GPs and benefited from the 
inclusion of participants from all four UK nations. It is of 
immediate relevance, taking into account that it assesses 
awareness of a disease which shows a rapidly rising inci-
dence and a changing epidemiology.
A total of 41 985 GPs (82.16% of the total number of 
registered GPs in the UK) were registered in England 
in September 2016, 4953 GPs, excluding locums, in 
Scotland in January 2017 (9.7%), 2887 GPs in Wales, 
including 634 locums, in March 2016 (5.6%) and 1274 
GPs, excluding locums, in Northern Ireland in October 
2015 (2.49%), respectively.19 Comparing these data with 
our sample, we need to acknowledge that participants 
from England (n=165; 44.2%) are under-represented and 
that participants from Scotland (n=103; 27.6%), Wales 
(n=32; 8.6%) and Northern Ireland (n=73; 19.6%) are 
over-represented. We instructed all participants to answer 
the questions consecutively when distributing the paper 
questionnaires, but they may have looked at subsequent 
questions which could have influenced their responses 
leading to an overestimation of knowledge. The online 
questionnaire only allowed questions to be answered in 
order. Although the response rate was high for a survey 
of GPs,20 we do not have data on non-responders so we 
are unable to test for response bias. The main limita-
tion of the study is the use of a convenience sample, 
recruited at GP educational events, and via email lists 
of event attendees and regional faculties. By recruiting 
participants attending training courses and educational 
events, we may have included GPs who were more up-to-
date, leading to an overestimation of knowledge levels. 
Training events included GP related topics in general and 
were not related to head and neck pathology or HPV. In 
Figure 1 Participant responses to questions on 10 proven risk factors for OPC, and 3 factors which are not known risk 
factors. OPC, oropharyngeal cancer. 
Table 2 Knowledge about HPV-associated OPC (n=342)
N %
Aware of OCP-HPV link before today?
  Yes 253 73.9
  No 58 16.9
  Not sure 31 9.1
Over the last two decades, have rates of HPV-OPC
  Increased 246 71.9
  Decreased 9 2.6
  Stayed the same 29 5.6
  Do not know 68 19.9
Compared with non-HPV-OPC, are HPV-OPC patients…
  Male 142 41.5
  Female 74 21.6
  Same gender 43 5.2
  Do not know 83 21.9
  Younger 201 58.8
  Older 48 14.1
  Same age 18 5.3
  Do not know 75 21.9
HPV, human papillomavirus; OPC, oropharyngeal cancer. 
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addition, we developed some of the questionnaire items 
specifically for the study and although they were reviewed 
by the study team and had good face validity, further 
psychometric validation would be appropriate prior to 
further use.
Comparison with the existing literature
A recent systematic review by Dodd et al evaluated the 
psychosocial impact of HPV-related HNC and investigated 
the awareness of the link between HPV and HNC among 
different populations. Forty-one studies were identified 
which measured knowledge of the link between HPV and 
HNC, demonstrating the lowest level of knowledge in the 
general population and highest in medical and dental 
professionals.21 However, Signorelli et al showed that only 
38% of Italian GPs (n=938) recognised the role of HPV 
in oral disease and oral cancer and concluded that there 
is a lack of knowledge on HPV infection and vaccination 
in Italian GPs.22 Odone et al explored reasons for non-vac-
cination against HPV in Italy,23 providing a useful basis 
to plan, implement and evaluate targeted educational 
programmes and training. The link between HPV and 
OPC was recognised by 43.3% of primary care physicians in 
Jordan24 and by 54% of a sample of German physicians.25
A study of 2126 adults in the USA demonstrated that 
knowledge of HNC among the general public is low. 
While 54% of participants identified smoking as a risk 
factor for HNC, 4.8% identified alcohol use and just 0.8% 
recognised HPV infection as a risk factor.14 Family physi-
cians could play a key role in educating the public and 
encouraging HPV vaccine uptake.
We report findings of the first study investigating the 
awareness of HPV-associated OPC risk factors in a sample 
of UK GPs. Awareness in the UK is high but there are gaps 
in knowledge that should be addressed.
Implications for practice
The failure of 41.2% of participants to recognise younger 
age as a characteristic of HPV-related OPC patients should 
be addressed. Good awareness of the fact that there has 
been a significant rise in younger patients presenting 
with OPC, often lacking a history of smoking and high 
alcohol intake, will help ensure that HPV-associated OPC 
is recognised early. Younger patients with HPV-associated 
OPC often present with asymmetrical tonsils and without 
knowledge of this disease and its presentation in the 
absence of classical risk factors makes it likely that early 
diagnosis is missed.
Our results clearly demonstrate the need for awareness 
campaigns to make UK GPs more aware of this rapidly 
evolving disease. We have created a learning module 
which can be freely accessed online (online supple-
mentary file 4; HPV-associated Oropharyngeal Cancer 
Module). This includes reference to other risk factors 
that we showed to be frequently underrecognised, such 
as chewing betel nuts (also referred to as catchu or areca 
nuts) which are traditional among some communities in 
Indian, Pakistan and Bangladesh.
In conclusion, this study suggests a clear need for 
further education for GPs on a disease which shows a 
rising incidence and a changing epidemiology .
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